Notice of Intent to Sole Source Beryllium Lymphocyte Proliferation Test (BeLPT) Services for Naval Health Clinic Hawaii
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) has awarded a Firm Fixed-Price contract to National Jewish Health for Beryllium Lymphocyte Proliferation Test (BeLPT) services for Naval Health Clinic Hawaii (NHCH). This was a sole source award, justified by the critical 24-48 hour sample viability requirement.
Scope of Work
The contract covers annual BeLPT services for an estimated 250 blood samples, used to determine beryllium sensitivity as mandated by OSHA for worker medical surveillance. Services include shipping, testing, interpretation, and reporting of results. All work will be performed at the contractor's CLIA-certified facility.
Contract & Timeline
- Type: Firm Fixed-Price
- Duration: A base year from February 1, 2026, to January 31, 2027, with four (4) option years, extending the period of performance through January 31, 2031.
- Set-Aside: Sole Source (Justified under FAR Subpart 13.5 in accordance with 41 U.S.C. 1901).
- Award Date: Published February 5, 2026.
- Place of Performance: Contractor Facility.
Evaluation
This award was made as a sole source after market research, including a Notice of Intent posted on SAM.gov, did not identify any other capable sources that could meet the strict 24-48 hour sample viability timeframe required for the BeLPT.
Additional Notes
The critical factor for this sole source justification is the strict 24-48 hour timeframe for blood sample viability after collection. National Jewish Health's location in Denver, Colorado, and established infrastructure are cited as essential for meeting this requirement. The previous contract for these services was also a sole source award.